FMC stock sentiment todayFMC Corp
Sentiment verdict
Gossip first, financials second — COLD at 85% confidence.
Last updated · cached analysis, refreshes periodically
FMC
FMC CorpA victim of the 'destocking' crisis, FMC is struggling with massive inventory gluts, high debt, and a dividend cut that has shattered investor confidence.
Pick a name and you can add your own 1-, 3- and 6-month price calls — no account needed. The needle above shows where the crowd sits. Calls lock 48 hours after you make them, so every scorecard stays honest.
You'll show up on boards and The Floor under this name. Add an email later to keep your history.
No account needed. You can add an email later to keep your calls.
Already have an account? Sign in
See exactly how analyst targets, gossip sentiment and momentum are weighted into this 6-month forecast.
Sign in to go Pro →Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for FMC. Not financial advice.
Price · last 12 months
Gossip
The narrative is dominated by the post-pandemic 'destocking' cycle in the agricultural sector, where distributors have stopped buying new chemicals to burn through existing supply. Recent sentiment plummeted further following a significant dividend reduction and repeated earnings misses.
- ·Inventory destocking in Brazil and India
- ·Recent 40% dividend cut to preserve cash
- ·Short-seller reports targeting patent cliff risks for Rynaxypyr
- ·Concerns over CEO transition and strategic direction
Financial
FMC is currently in a liquidity crunch with a bloated balance sheet. Revenue growth has turned sharply negative, and the debt-to-EBITDA ratio has spiked dangerously, forcing management to prioritize debt repayment over shareholder returns.
- ·Negative Free Cash Flow in recent quarters
- ·High Net Debt/EBITDA (>4.0x)
- ·Shrinking EBITDA margins due to lower volumes and pricing pressure
- ·P/E ratio appears low (~10x) but is skewed by declining forward estimates
Conviction
Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.
Quiet accumulation — the chatter is cold but the smart money is leaning in.
- ·No open-market insider trades in the last 120 days.
Pro shows every named insider trade in the window (buyer, title, size, price, and whether it was a pre-scheduled 10b5-1 sale) plus the full holder register split into patient capital and fast money.
Unlock with Pro →Source: SEC EDGAR Form 4 + 13F holder register. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.
Risks
- ·Continued weakness in the Brazilian agricultural market
- ·Loss of patent protection for key insecticide blockbusters
- ·Interest rate sensitivity due to high floating-rate debt levels
- ·Potential for further downward guidance revisions
Peer temperature
How direct competitors stack up against FMC right now.
- NEUTRALCTVACorteva, Inc.
HOTTER — maintains a more resilient seed business to offset crop protection volatility and has a much healthier balance sheet.
See full analysis → - NEUTRALBASFYBASF SE
WARMER — offering better diversification across industrial chemicals, though still facing European energy cost headwinds.
See full analysis → - COLDSYTSyngenta Group
SIMILAR — facing the same severe destocking pressures in key global markets while dealing with its own IPO delays.
See full analysis →
- FMC+17.5%
- CTVA+10.8%
- BASFY+3.0%
- SYT—
Analyst price target
Consensus average of 13 analysts · median 12.00
Source: StockAnalysis.com · updated 2026-08-25
AI-generated analysis for informational purposes only. Not financial advice.